Work

Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: preliminary results

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz157.002

Authors: I. Matos, L. Goyal, J. Cleary, M. Voss, D. Oh, F. Meric Bernstam, C. Ng, G. Iyer, N. Ishii, Y. Hu, A. Vaslin Chessex, A. Pokorska-Bocci, V. Nicolas, Y. Kirpicheva, C. Zanna, K. Flaherty, J. Tabernero, D. Hyman

Institutions: Vall d'Hebron Hospital Universitari, Massachusetts General Hospital, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Seoul National University Hospital, The University of Texas MD Anderson Cancer Center, National Cancer Centre Singapore, Chugai Pharmaceutical Co., Ltd. (Japan), Debiopharm (Switzerland), Vall d'Hebron Institute of Oncology

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2958176014

FWCI: 0.215

Cites:

Cited by: 4

Related to: 10